Figure. A man in a grey suit, light tie, and striped shirt smiles at the camera against a white background.

Michael M. Halassa, MD, PhD

Professor and Director of Translational Research, Department of Neuroscience; Professor, Department of Psychiatry, Tufts University School of Medicine, Boston, Massachusetts

  • 3Articles
  • 2025–2026Active
  • 4Collaborators

About

Michael M. Halassa, MD, PhD is affiliated with Professor and Director of Translational Research, Department of Neuroscience; Professor, Department of Psychiatry, Tufts University School of Medicine, Boston, Massachusetts. Michael M. Halassa has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2025 and 2026. Their work focuses on Schizophrenia/Schizoaffective Disorders and Psychotic Disorders.

Publications

JCP
Clinical pearls of early use of Xanomeline–Trospium in the in-patient setting with Michael Halassa MD, PhD
Podcast

Clinical pearls of early use of Xanomeline–Trospium in the in-patient setting with Michael Halassa MD, PhD

February 10, 2026

Dr. Halassa shares clinical insights on xanomeline-trospium for inpatient schizophrenia, addressing negative symptoms and treatment-resistant cases.
,
JCP
Developing Algorithmic Psychiatry with Michael Halassa MD, PhD
Podcast

Developing Algorithmic Psychiatry with Michael Halassa MD, PhD

January 27, 2026

,
JCP
Real-World Implementation of Xanomeline-Trospium in Schizophrenia: A Consensus Panel Report
Academic Highlights

Real-World Implementation of Xanomeline-Trospium in Schizophrenia: A Consensus Panel Report

November 7, 2025

A consensus panel outlines strategies for real-world clinical implementation of xanomeline-trospium in the treatment of adult patients with schizophrenia
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe